V002-7630 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

V002-7630 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide
V002-7630 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-7630
N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-7630

Molecular Formula

C30H35N3O6S (C30 H35 N3 O6 S)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

SMILES

Cc1c(CN(Cc(cc2)cc3c2OCO3)C(CN(CCN2CCOCC2)C(c(cc2)ccc2OC)=O)=O)scc1

InChI

InChI=1S/C30H35N3O6S/c1-22-9-16-40-28(22)19-33(18-23-3-8-26-27(17-23)39-21-38-26)29(34)20-32(11-10-31-12-14-37-15-13-31)30(35)24-4-6-25(36-2)7-5-24/h3-9,16-17H,10-15,18-21H2,1-2H3

InChI Key

QGIPDWNPNLQLIK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19763377

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

565.69

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.212

Distribution Coefficient, logD

3.208

Water Solubility, LogSw

-3.25

Polar Surface Area

69.409

Acid Dissociation Constant (pKa)

21.89

Base Dissociation Constant (pKb)

5.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V002-7630 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V002-7630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-7630?
Check Price and Availability of V002-7630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-7630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-7630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-7630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-7630 available by request